CIK 0001503802 · Non-accelerated filer<br>Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 263931704
- Phone
- 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-04 | Paulson Richard A. President and CEO | Sale | −3,592 | $0.99 | $4K | 1,150,105 |
| 2024-06-04 | PAKIANATHAN DEEPIKA Director | Sale | −337,742 | $0.95 | $322K | 810,133 |
| 2024-06-04 | PAKIANATHAN DEEPIKA Director | Sale | −3,298 | $0.95 | $3K | 7,911 |
| 2024-06-03 | PAKIANATHAN DEEPIKA Director | Sale | −357,256 | $1.00 | $358K | 1,147,875 |
| 2024-06-03 | PAKIANATHAN DEEPIKA Director | Sale | −3,488 | $1.00 | $3K | 11,209 |
| 2024-05-31 | PAKIANATHAN DEEPIKA Director | Sale | −202,418 | $0.95 | $193K | 1,505,131 |
| 2024-05-31 | PAKIANATHAN DEEPIKA Director | Sale | −1,976 | $0.95 | $2K | 14,697 |
| 2024-05-29 | Su Zhen Director | Grant or award · Nonstatutory Stock Option (right to buy) | +50,587 | 50,587 | ||
| 2024-05-29 | Schor Chen Director | Grant or award · Nonstatutory Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2024-05-29 | PAKIANATHAN DEEPIKA Director | Grant or award · Nonstatutory Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2024-05-29 | Oliger Christy J. Director | Grant or award · Nonstatutory Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2024-05-29 | Mirza Mansoor Raza Director | Grant or award · Nonstatutory Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2024-05-29 | Greene Barry E Director | Grant or award · Nonstatutory Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2024-05-29 | BOHLIN GAREN G Director | Grant or award · Nonstatutory Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2024-05-06 | Paulson Richard A. President and CEO | Sale | −3,576 | $1.13 | $4K | 1,153,697 |
| 2024-04-22 | Rangwala Reshma EVP & Chief Medical Officer | Sale | −6,789 | $1.17 | $8K | 342,931 |
| 2024-04-04 | Paulson Richard A. President and CEO | Sale | −3,563 | $1.29 | $5K | 1,157,273 |
| 2024-03-05 | Paulson Richard A. President and CEO | Sale | −3,573 | $1.30 | $5K | 1,160,836 |
Page 7 of 7 · 138 trades